ArticleInternational journal of molecular sciences2023

Differences in Whole-Blood Transcriptional Profiles in Inflammatory Bowel Disease Patients Responding to Vedolizumab Compared with Non-Responders.

Sofie Haglund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.